Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-24-000076

CEO sold 12,191 shares at $5.50 ($66,997)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-04 Sale : show line 1 in the form 10b5-1 −12,191 $5.50 $66,997 315,279 D
Open-market sales · 12,191 sh · avg $5.50 · $66,997
Loading xslF345X05/wk-form4_1717705020.xml…